enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
-
Believers rejoice as Jerusalem's holy sites re-open
-
EU lawmakers want to tax Big Tech to fund budget
-
Croke Park boss eager to stage Fury-Joshua heavyweight clash in Dublin
-
Cannes Festival promises escapism in Hollywood-lite edition
-
Stabbed for saying no: Is online misogyny fueling violence in Brazil?
-
Russia's Nobel Prize-winning rights group Memorial branded 'extremist'
-
McIlroy ready for early start as 90th Masters begins
-
Fonseca eases into Monte Carlo last eight meeting with Zverev
-
Verstappen set for fresh F1 angst as engineer nears Red Bull exit - reports
-
Farhadi, Almodovar, Zvyagintsev to vie for top Cannes Festival prize
-
Ambitious Como's Champions League bid tested by Serie A leaders Inter
-
Emperor penguins listed as endangered species: IUCN
-
Six new caps for France for women's Six Nations opener
-
Calls for US-Iran truce to extend to Lebanon after Israeli strikes
-
Nepal ex-PM Oli gives defiant message after release from custody
-
Despite Middle East truce, airlines fear long-term disruptions
-
Memorial: Russia's Nobel Prize winning rights group facing 'extremism' ban
-
Artemis crew's families enthralled by messages from space
-
Champions Cup 'heartbreak' driving Toulouse revenge mission
-
Shallow Indonesian quake damages houses, injures residents
-
Nepal ex-PM Oli released from custody after 12 days: police
-
'Chills': Artemis astronauts say lunar flyby still washing over them
-
Ukraine lets firms deploy air defences against Russian attacks
-
Mountain-made: Balkan sheepdog eyes future beyond the hills
-
Escaped wolf forces school closure in South Korea
-
Three ways Orban gives himself an edge in Hungary's vote
-
Trump says US military to stay deployed near Iran until 'real agreement' reached
-
Gender-row boxer Lin targets Asian Games after bronze on comeback
-
US-Iran truce shows cracks as war flares in Lebanon
-
In Romania, many Hungarians root for Orban in vote
-
Home where young Bowie dreamt of 'fame' to open to public
-
Crude rises, stocks fall on fears over nascent Iran ceasefire
-
Waiting for DeepSeek: new model to test China's AI ambitions
-
You're being watched: Japan battles online abuse of athletes
-
US court expedites Anthropic's legal battle with Department of War
-
Badminton to trial synthetic shuttlecocks because of feather shortage
-
Firm, fast Augusta set to test golf's best in 90th Masters
-
BTS to kick off world tour after landmark Seoul comeback
-
Grand National had to change to survive, says former winning jockey
-
Maple syrup or nutella? PM Carney calls Canadian Artemis astronaut
-
Comedy duo Flight of the Conchords reunion gigs sell out in minutes
-
US-Iran truce enters second day as war flares in Lebanon
-
Trump blasts NATO after closed-door Rutte meeting
-
Houston, we have a problem ... with the toilet
-
XCF Global Provides Update on New Rise Reno Plant Conversion
-
New Generation Consumer Group Inc. (NGCG) Announces Strategic Entry into AI Infrastructure to Capture Rapidly Expanding High-Performance Computing Demand
-
GPOPlus+ Launches First National Ad Campaign to Expand DSD Network
-
Vertical Data Announces $43M AI Infrastructure Partnership with AlphaTON Capital Corp.
-
OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
-
Perpetuals.com Launches Strategic Initiative to Deploy Next-Generation Agentic AI Infrastructure Platform for Fintech and Digital Assets Industry; Secures Exclusive License for Proprietary On-Premises Quantitative Research Platform "Forgentiq.ai"
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
Watch the "What This Means" video here
IRVINE, CA / ACCESS Newswire / September 26, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment.
As part of the segment, Mr. Berman discussed the Company's recent news announcing it filed a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a surgical replacement venous valve for treating severe deep chronic venous insufficiency (CVI).
The Virtual Investor "What This Means" segment featuring enVVeno Medical is now available here.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of severe deep Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The Company is currently performing the final testing necessary to seek IDE approval from the FDA to begin the U.S. pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
T.Perez--AT